ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 123 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2022. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $184,933 | -4.5% | 91,100 | +8.2% | 0.00% | – |
| Q2 2023 | $193,591 | +11.5% | 84,170 | +46.9% | 0.00% | – |
| Q1 2023 | $173,619 | +51.8% | 57,300 | +16.7% | 0.00% | – |
| Q4 2022 | $114,403 | +87.5% | 49,100 | +54.4% | 0.00% | – |
| Q3 2022 | $61,000 | -7.6% | 31,800 | +31.4% | 0.00% | – |
| Q2 2022 | $66,000 | +57.1% | 24,200 | +71.6% | 0.00% | – |
| Q1 2022 | $42,000 | -23.6% | 14,100 | 0.0% | 0.00% | – |
| Q4 2021 | $55,000 | -8.3% | 14,100 | 0.0% | 0.00% | – |
| Q3 2021 | $60,000 | +39.5% | 14,100 | 0.0% | 0.00% | – |
| Q2 2021 | $43,000 | -84.8% | 14,100 | -52.7% | 0.00% | – |
| Q3 2018 | $282,000 | – | 29,821 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Two Seas Capital LP | 825,569 | $3,211,000 | 2.46% |
| GREAT POINT PARTNERS LLC | 668,907 | $2,602,000 | 0.58% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 270,000 | $1,050,000 | 0.47% |
| QCM Cayman, Ltd. | 10,205 | $40,000 | 0.24% |
| Pitti Group Wealth Management, LLC | 50,000 | $195,000 | 0.22% |
| RTW INVESTMENTS, LP | 2,504,493 | $9,742,000 | 0.14% |
| Hudson Bay Capital Management LP | 1,805,700 | $7,024,000 | 0.07% |
| Quinn Opportunity Partners LLC | 276,485 | $1,076,000 | 0.07% |
| Kepos Capital LP | 200,000 | $778,000 | 0.06% |
| XTX Topco Ltd | 29,026 | $113,000 | 0.06% |